BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24121191)

  • 21. Glycomics approach to structure-function relationships of glycosaminoglycans.
    Sasisekharan R; Raman R; Prabhakar V
    Annu Rev Biomed Eng; 2006; 8():181-231. PubMed ID: 16834555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins.
    Zhang L
    Prog Mol Biol Transl Sci; 2010; 93():1-17. PubMed ID: 20807638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex coacervation-based loading and tunable release of a cationic protein from monodisperse glycosaminoglycan microgels.
    Schuurmans CCL; Abbadessa A; Bengtson MA; Pletikapic G; Eral HB; Koenderink G; Masereeuw R; Hennink WE; Vermonden T
    Soft Matter; 2018 Aug; 14(30):6327-6341. PubMed ID: 30024582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins.
    Hileman RE; Fromm JR; Weiler JM; Linhardt RJ
    Bioessays; 1998 Feb; 20(2):156-67. PubMed ID: 9631661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Tunable Glycosaminoglycan-Peptide Nanoparticle Platform for the Protection of Therapeutic Peptides.
    Sodhi H; Panitch A
    Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sulfated glycosaminoglycan array for molecular interactions between glycosaminoglycans and growth factors or anti-glycosaminoglycan antibodies.
    Takada W; Fukushima M; Pothacharoen P; Kongtawelert P; Sugahara K
    Anal Biochem; 2013 Apr; 435(2):123-30. PubMed ID: 23333222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of a glycosaminoglycan binding site on interleukin-10 via molecular simulation methods.
    Gehrcke JP; Pisabarro MT
    J Mol Graph Model; 2015 Nov; 62():97-104. PubMed ID: 26409190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific sides to multifaceted glycosaminoglycans are observed in embryonic development.
    Kramer KL
    Semin Cell Dev Biol; 2010 Aug; 21(6):631-7. PubMed ID: 20599516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New targets for glycosaminoglycans and glycosaminoglycans as novel targets.
    Gesslbauer B; Theuer M; Schweiger D; Adage T; Kungl AJ
    Expert Rev Proteomics; 2013 Feb; 10(1):77-95. PubMed ID: 23414361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling large protein-glycosaminoglycan complexes using a fragment-based approach.
    Samsonov SA; Zacharias M; Chauvot de Beauchene I
    J Comput Chem; 2019 May; 40(14):1429-1439. PubMed ID: 30768805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast enhanced computed tomography for real-time quantification of glycosaminoglycans in cartilage tissue engineered constructs.
    Garcia JP; Longoni A; Gawlitta D; J W P Rosenberg A; Grinstaff MW; Töyräs J; Weinans H; Creemers LB; Pouran B
    Acta Biomater; 2019 Dec; 100():202-212. PubMed ID: 31580960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sweet but Challenging: Tackling the Complexity of GAGs with Engineered Tailor-Made Biomaterials.
    Le Pennec J; Picart C; Vivès RR; Migliorini E
    Adv Mater; 2024 Mar; 36(11):e2312154. PubMed ID: 38011916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tilorone-induced lysosomal lesions: the bisbasic character of the drug is essential for its high potency to cause storage of sulphated glycosaminoglycans.
    Fischer J; Hein L; Lüllmann-Rauch R; von Witzendorff B
    Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):369-75. PubMed ID: 8615802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.
    Pieper JS; Hafmans T; Veerkamp JH; van Kuppevelt TH
    Biomaterials; 2000 Mar; 21(6):581-93. PubMed ID: 10701459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defined surface immobilization of glycosaminoglycan molecules for probing and modulation of cell-material interactions.
    Wang K; Luo Y
    Biomacromolecules; 2013 Jul; 14(7):2373-82. PubMed ID: 23682647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.
    Handel TM; Johnson Z; Crown SE; Lau EK; Proudfoot AE
    Annu Rev Biochem; 2005; 74():385-410. PubMed ID: 15952892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and functional insights into sclerostin-glycosaminoglycan interactions in bone.
    Salbach-Hirsch J; Samsonov SA; Hintze V; Hofbauer C; Picke AK; Rauner M; Gehrcke JP; Moeller S; Schnabelrauch M; Scharnweber D; Pisabarro MT; Hofbauer LC
    Biomaterials; 2015 Oct; 67():335-45. PubMed ID: 26232882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chapter 4. Interactions of chemokines with glycosaminoglycans.
    Hamel DJ; Sielaff I; Proudfoot AE; Handel TM
    Methods Enzymol; 2009; 461():71-102. PubMed ID: 19480915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced lysosomal storage of sulphated glycosaminoglycans.
    Fischer J; Lüllmann H; Lüllmann-Rauch R
    Gen Pharmacol; 1996 Dec; 27(8):1317-24. PubMed ID: 9304401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the glycosaminoglycan-protein interaction network by glycan-mediated pull-down proteomics.
    Gesslbauer B; Derler R; Handwerker C; Seles E; Kungl AJ
    Electrophoresis; 2016 Jun; 37(11):1437-47. PubMed ID: 26970331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.